Bengaluru: Siddharth Mittal has officially assumed the role of Managing Director and Chief Executive Officer of Syngene International, a global contract research, development, and manufacturing organization (CRDMO), with effect from 1 July 2026.
Siddharth Mittal succeeds Peter Bains, who completed his tenure as Managing Director & CEO on 30 June 2026. Mittal brings nearly three decades of business leadership experience to the role and joins Syngene from Biocon Limited, where he most recently served as Managing Director and Chief Executive Officer.
During his 13-year tenure at Biocon, Siddharth Mittal initially served as Chief Financial Officer before being appointed Managing Director and CEO. During this period, he played a pivotal role in shaping the company’s strategic direction for long-term growth.
His leadership helped strengthen commercial operations, expand Biocon’s presence across global markets, secure key regulatory approvals, and successfully commercialize the company’s GLP-1 portfolio across major international markets.
In addition, Siddharth Mittal led strategic partnerships and commercial initiatives that strengthened Biocon’s competitive position while driving operational excellence, customer-centricity, and sustainable business growth.
Kiran Mazumdar-Shaw, Executive Chairperson of Syngene International, said: “I am delighted to welcome Siddharth as the Managing Director and CEO of Syngene. Having worked closely with Siddharth for many years, I have seen first hand his ability to lead businesses through period of change, build strong teams and deliver transformation and sustainable growth. Having built a strong reputation for scientific excellence, quality and customer trust, Syngene is now at an inflection point in its journey.
As the industry evolves and customer expectations continue to rise, I am confident Siddharth’s leadership, commercial acumen and execution focus will help Syngene unlock its full potential and create long-term value for our customers, employees and shareholders.”
Also Read: Shreehas Tambe Appointed CEO and Managing Director of Biocon Limited Effective April 1, 2026
Siddharth Mittal said: “I am honoured to take on the role of Managing Director and CEO of Syngene. Over the years, the company has built exceptional scientific capabilities, a talented team, and gained the trust of customers across the world. These enduring strengths give us a solid platform to drive the next phase of long-term growth. My immediate priority is to sharpen our commercial edge, strengthen delivery excellence and bring greater focus and discipline to execution across the business.
By combining our scientific strengths and talented workforce with an unwavering focus on customer fulfilment and cost competitiveness, I am confident that we can restore growth momentum and reinforce Syngene’s standing as a global leader in CRDMO services, while creating long-term value for all our stakeholders.”
The appointment of Siddharth Mittal marks a leadership transition at Syngene International as the company continues to strengthen its position as a global CRDMO.
With extensive experience in finance, commercial strategy, regulatory expansion, global market development, and operational leadership, Siddharth Mittal will now lead the company’s next phase of growth following the completion of Peter Bains’ tenure.
